Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Strobel

Showing results (221-230 of 236) with videos related to

Pageof 24
Sort By:
International Journal of Cancer|February 3, 2021
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibilityChiara Corradi, Manuel Gentiluomo, László Gajdán, et al.
International Journal of Cancer|October 17, 2018
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA studyDaniele Campa, Martina Matarazzi, William Greenhalf, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 11, 2026
International consensus on mesopancreas and total mesopancreas excision (MESODELPHI)Luís Felipe Leite, Marcos Belotto, Marcelo Sá de Araújo, et al.
International Journal of Cancer|September 16, 2017
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigationDaniele Campa, Manuela Pastore, Gabriele Capurso, et al.
International Journal of Cancer|April 10, 2020
Genome-wide association study identifies an early onset pancreatic cancer risk locusDaniele Campa, Manuel Gentiluomo, Ofure Obazee, et al.
Carcinogenesis|July 3, 2021
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinomaLaura Pistoni, Manuel Gentiluomo, Ye Lu, et al.
Oncotarget|August 4, 2016
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer riskDaniele Campa, Manuela Pastore, Manuel Gentiluomo, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Journal of Medical Genetics|June 28, 2020
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk predictionAlice Alessandra Galeotti, Manuel Gentiluomo, Cosmeri Rizzato, et al.
The Lancet. Oncology|March 5, 2026
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancerCarl-Stephan Leonhardt, Mustapha Adham, Shouki Bazarbashi, et al.
Pageof 24

Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
International Journal of Cancer|February 3, 2021
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibilityChiara Corradi, Manuel Gentiluomo, László Gajdán, et al.
International Journal of Cancer|October 17, 2018
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA studyDaniele Campa, Martina Matarazzi, William Greenhalf, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 11, 2026
International consensus on mesopancreas and total mesopancreas excision (MESODELPHI)Luís Felipe Leite, Marcos Belotto, Marcelo Sá de Araújo, et al.
International Journal of Cancer|September 16, 2017
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigationDaniele Campa, Manuela Pastore, Gabriele Capurso, et al.
International Journal of Cancer|April 10, 2020
Genome-wide association study identifies an early onset pancreatic cancer risk locusDaniele Campa, Manuel Gentiluomo, Ofure Obazee, et al.
Carcinogenesis|July 3, 2021
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinomaLaura Pistoni, Manuel Gentiluomo, Ye Lu, et al.
Oncotarget|August 4, 2016
Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer riskDaniele Campa, Manuela Pastore, Manuel Gentiluomo, et al.
JAMA Oncology|January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Journal of Medical Genetics|June 28, 2020
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk predictionAlice Alessandra Galeotti, Manuel Gentiluomo, Cosmeri Rizzato, et al.
The Lancet. Oncology|March 5, 2026
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancerCarl-Stephan Leonhardt, Mustapha Adham, Shouki Bazarbashi, et al.
Pageof 24